ImpediMed develops bioimpedance devices with a focus on medical applications in the fluid status area. Primary to this is the L-Dex U400 which measures extracellular fluid differences in the limbs for unilateral lymphedema.
The company is pioneering the use of next generation bioimpedance technology both in BIS (Bioimpedance Spectroscopy).
June 21, 2017
Notification under section 708A(5)(e) of the Corporations Act 2001 (Cth)
View the PDF